Cargando…
RNAi-mediated siRNA sequences to combat the COVID-19 pandemic with the inhibition of SARS-CoV2
The outbreak of the COVID-19 pandemic has cost five million lives to date, and was caused by a positive-sense RNA virus named SARS-CoV2. The lack of drugs specific to SARS-CoV2, leads us to search for an effective and specific therapeutic approach. Small interfering RNA (siRNA) is able to activate t...
Autor principal: | Saadat, Khandakar A.S.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760737/ https://www.ncbi.nlm.nih.gov/pubmed/35071824 http://dx.doi.org/10.1016/j.genrep.2022.101512 |
Ejemplares similares
-
RNAi therapeutics: Can siRNAs conquer SARS?
por: Chang, Z, et al.
Publicado: (2005) -
Inhibition of SARS-CoV replication by siRNA
por: Wu, Chang-Jer, et al.
Publicado: (2005) -
siRNA targeting the Leader sequence of SARS-CoV inhibits virus replication
por: Li, T, et al.
Publicado: (2005) -
RNAiAtlas: a database for RNAi (siRNA) libraries and their specificity
por: Mazur, Sławek, et al.
Publicado: (2012) -
RNAi‐mediated endogene silencing in strawberry fruit: detection of primary and secondary siRNAs by deep sequencing
por: Härtl, Katja, et al.
Publicado: (2017)